Calderon, S. N., Hunt, J., & Klein, M. (2018). A regulatory perspective on the evaluation of hallucinogen drugs for human use. Neuropharmacology, 142, 135-142. https://doi.org/10.1016/j.neuropharm.2017.11.028
Chicago Style (17th ed.) CitationCalderon, Silvia N., Joshua Hunt, and Michael Klein. "A Regulatory Perspective on the Evaluation of Hallucinogen Drugs for Human Use." Neuropharmacology 142 (2018): 135-142. https://doi.org/10.1016/j.neuropharm.2017.11.028.
MLA (9th ed.) CitationCalderon, Silvia N., et al. "A Regulatory Perspective on the Evaluation of Hallucinogen Drugs for Human Use." Neuropharmacology, vol. 142, 2018, pp. 135-142, https://doi.org/10.1016/j.neuropharm.2017.11.028.
Warning: These citations may not always be 100% accurate.